EP
DXCM icon

Essential Partners’s DexCom DXCM Stock Holding History

Essential Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63.5K Sell
736
-9
-1% -$749 0.03% 549
2026
Q2 		$50.2K Sell
745
-1,072
-59% -$71.4K 0.02% 617
2026
Q1 		$114K Sell
1,817
-320
-15% -$22.3K 0.04% 392
2025
Q4 		$142K Sell
2,137
-1,423
-40% -$92K 0.04% 377
2025
Q3 		$240K Buy
3,560
+135
+4% +$10.7K 0.08% 291
2025
Q2 		$299K Buy
+3,425
New +$268K 0.12% 230

Other funds holding DXCM

Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Fisher Funds Management
Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Beacon Investment Advisory Services
Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return
Gradient Investments
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
HH
HWG Holdings Houston, Texas $434M AUM 42.17% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Essential Partners's DXCM Position: Q3 2026 in Review

Essential Partners reduced its DexCom (DXCM) stake by 1.2% in Q3 2026, selling an estimated $749 and leaving 736 shares worth $63.5K. The position accounts for 0.03% of the portfolio, ranked #549.

Essential Partners first reported a position in DXCM in Q2 2025 and has held it in 6 quarters since. The position peaked at $299K in Q2 2025. 135 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Essential Partners held 736 shares of DexCom worth $63.5K as of Q3 2026.
  • Essential Partners sold 9 DexCom shares in Q3 2026, an estimated $749.
  • DexCom made up 0.03% of Essential Partners's portfolio in Q3 2026, its #549 holding.
  • Essential Partners first reported a position in DexCom in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's DexCom position peaked at $299K in Q2 2025.
  • 135 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.